Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies.
Alexander I SpiraAaron R HansenWael A HarbKelly K CurtisErina Koga-YamakawaMakoto OriguchiZhonggai LiBella ErtikWalid L ShaibPublished in: Targeted oncology (2021)
ClinicalTrials.gov identifier: NCT02498665.